Shopping Cart
Remove All
Your shopping cart is currently empty
Anticancer agent 122, a potent inhibitor of human lactate dehydrogenase A (h LDHA), exhibits significant anticancer activities, rendering it suitable for use in cancer research [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | Anticancer agent 122, a potent inhibitor of human lactate dehydrogenase A (h LDHA), exhibits significant anticancer activities, rendering it suitable for use in cancer research [1]. |
| In vitro | Anticancer agent 122 (Compound 8m) inhibits the growth of liver cancer cells (HepG2) and cervical cancer cells (SiHa) with IC50 values of 5.15 μM and 1.65 μM, respectively, at concentrations of 0-100 μM over 72 hours, and shows no significant toxicity toward the human embryonic kidney cell line (HEK293) [1]. |
| Molecular Weight | 358.84 |
| Formula | C18H15ClN2O2S |
| Cas No. | 2924532-50-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.